Fosaprepitant

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 17 USDMF, 3 JDMF, 5 EU WC, 3 KDMF, 13 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

19 Drugs in Development

19 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers, 24 FDA Orange Book, 4 Europe, 1 Canada, 8 Australia, 4 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 3 Actylis, 1 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 4 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 8 Parenteral, 7 Direct Compression, 3 Granulation, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 3 Thickeners and Stabilizers, 3 Topical, 2 Film Formers & Plasticizers, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients